Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Has results
×
Endometrial Neoplasms
×
olaparib
×
Clear all
Filters
3
NCT04269200
2025-12-23
DUO-E
AstraZeneca
Phase 3
Active not recruiting
805 enrolled
18 charts
1 FDA
NCT02506816
2020-11-30
Polen
MedSIR
Completed
36 enrolled
10 charts